Differential metabolism of dynorphins in substantia nigra, striatum, and hippocampus

Peptides

Volumn 18, Issue 7, 1997, Pages 949-956

  Sandin, Johan ^a   Tan no, Koichi ^b   Kasakov, Lubomir ^a   Nylander, Ingrid ^c   Winter, Anders ^d   Silberring, Jerzy ^a,e   Terenius, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c UPPSALA UNIVERSITY   (Sweden)

^d GE Healthcare Bio Sciences AB   (Sweden)

^e JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Dynorphin; Enkephalin; HPLC; Mass spectrometry; Metabolism; Peptidases

Indexed keywords

ALPHA NEOENDORPHIN; DYNORPHIN A; DYNORPHIN B; LEUCINE ENKEPHALIN;

ANIMAL TISSUE; ARTICLE; BRAIN METABOLISM; BRAIN REGION; CORPUS STRIATUM; GEL PERMEATION CHROMATOGRAPHY; HIPPOCAMPUS; HORMONE METABOLISM; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DYNORPHINS; ENDORPHINS; ENKEPHALIN, LEUCINE; HIPPOCAMPUS; MALE; MASS SPECTROMETRY; PROTEIN PRECURSORS; RATS; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

ANIMALIA;

EID: 0030724785     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00025-9     Document Type: Article

References (40)

1. Albertioni F., Hassan M., Silberring J., Liliemark J. Kinetics and metabolism of 2-chloro-2′-deoxyadenosine and 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine in the isolated perfused rat liver. Eur. J. Drug Metab. Pharmacokinet. 20:1995;225-232.
2. Andén N. E., Stock G. Inhibitory effect of γ-hydroxybutyric acid and γ-aminobutyric acid on dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 279:1973;89-92.
3. Berman Y. L., Juliano L., Devi L. A. Purification and characterization of a dynorphin-processing endopeptidase. J. Biol. Chem. 270:1995;23845-23850.
4. Chavkin C., Bakhit C., Weber E., Bloom F. E. Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus. Proc. Natl. Acad. Sci. USA. 80:1983;7669-7673.
5. Christensson-Nylander I., Herrera-Marschitz M., Staines W., Hökfelt T., Terenius L., Ungerstedt U., Cuello C. Striato-nigral dynorphin and substance P pathways in the rat I. Biochemical and immunohistochemical studies. Exp. Brain Res. 64:1986;169-192.
6. Graybiel A. M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-254.
7. Herrera-Marschitz M., Christensson-Nylander I., Sharp T., Staines W., Reid M., Hökfelt T., Terenius L., Ungerstedt U. Striato-nigral dynorphin and substance P pathways in the rat II. Functional analysis. Exp. Brain Res. 64:1986;193-197.
8. Hooper N. M., Kenny A. J., Turner A. J. The metabolism of neuropeptides. Neurokinin A (substance K) is a substrate for endopeptidase 24.11 but not for peptidyl dipeptidase A (angiotensin converting enzyme). Biochem. J. 231:1985;357-361.
9. Höllt V. Opioid peptide processing and receptor selectivity. Annu. Rev. Pharmacol. Toxicol. 26:1986;59-77.
10. Kakidani H., Furutani Y., Takahashi H., Noda M., Morimoto Y., Hirose T., Asai M., Inayama S., Nakanishi S., Numa S. Cloning and sequence analysis of cDNA for porcine β-neo-endorphin/dynorphin precursor. Nature. 298:1982;245-249.
11. Kameyama T., Ukai M., Miura M. Dynorphin A-(1-13) potently improves galanin-induced impairment of memory processes in mice. Neuropharmacology. 33:1994;1167-1169.
12. Kobayashi R., Yun S.-X., Walsh J. H. Angiotensin-converting enzyme in the rabbit stomach wall. Gastroenterology. 100:1991;25-32.
13. Koide S., Onishi H., Katayama M., Yamagami S. Metabolic profile of opioid peptides differs in the hippocampus and striatum of seizure-susceptible E1 mice. Neurochem. Res. 20:1995;279-283.
14. Li Y.-T., Hsieh Y.-L., Henion J. D., Senko M. W., McLafferty F. W., Ganem B. Mass spectrometric studies on noncovalent dimers of leucine zipper peptides. J. Am. Chem. Soc. 115:1993;8409-8413.
15. Marks N., Berg M. J., Benuck M., Lo E. S., Novachenko H., Seyfried C. A. Prodynorphin processing by rat CNS fractions and purified enzymes Formation of dynorphin A 1-8 by sulfhydryl-activated carboxypeptidase and peptidyl dipeptidase. Neurochem. Int. 10:1994;413-422.
16. McDaniel K. L., Mundy W. R., Tilson H. A. Microinjection of dynorphin into the hippocampus impairs spatial learning in rats. Pharmacol. Biochem. Behav. 35:1990;429-435.
17. McGinty J. F., Henriksen S. J., Goldstein A., Terenius L., Bloom F. E. Dynorphin is contained within hippocampal mossy fibers Immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc. Natl. Acad. Sci. USA. 31:1982;1797-1800.
18. McKnight A. T., Corbett A. D., Kosterlitz H. W. Increase in potencies of opioid peptides after peptidase inhibition. Eur. J. Pharmacol. 86:1983;393-402.
19. Minamoto N., Kangawa K., Fukuda A., Matsuo H. A new opioid octapeptide related to dynorphin from porcine hypothalamus. Biochem. Biophys. Res. Commun. 95:1980;1475-1481.
20. Morris R. G. M., Garrud P., Rawlins J. N. P., O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature. 297:1982;681-683.
21. Nyberg F., Le Greves P., Terenius L. Modulation of endopeptidase activity by calcitonin gene related peptide A mechanism affecting substance P action? Biochemie. 70:1988;65-68.
22. Nyberg F., Silberring J. Conversion of dynorphins to Leu-enkephalin in human spinal cord. Prog. Clin. Biol. Res. 328:1990;261-264.
23. Nylander I., Terenius L. Dopamine receptors mediate alterations in striato-nigral dynorphin and substance P pathways. Neuropharmacology. 26:1987;1295-1302.
24. Nylander I., Tan-No K., Winter A., Silberring J. Processing of prodynorphin-derived peptides in striatal extracts Identification by electrospray ionization mass spectrometry hyphenated to size-exclusion chromatography. Life Sci. 57:1995;123-129.
25. Nylander I., Vlaskovska M., Terenius L. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats. Psychopharmacology. 118:1995;391-400.
26. Roepstorff P., Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass. Spectrom. 11:1984;601.
27. Sandin J., Nylander I., Georgieva J., Schött P. A., Ögren S. O., Terenius L. The effects of dynorphin B on spatial learning and memory when microinjected into the hippocampus of the rat. Analgesia. 1:(4\N6):1995;691-694.
28. Shippenberg T. S., Herz A., Spanagel R., Bals-Kubik R., Stein C. Conditioning of opioid reinforcement Neuroanatomical and neurochemical substrates. Ann. N.Y. Acad. Sci. 654:1992;347-356.
29. Silberring J., Castello M. E., Nyberg F. Characterization of dynorphin A-converting enzyme in human spinal cord An endoprotease related to a distinct conversion pathway for the opioid heptadecapeptide? J. Biol. Sci. 267:1992;21324-21328.
30. Silberring J., Lason W., Przewlocka B., Przewlocki R. Enkephalin convertase in the rat spinal cord. Neuropeptides. 8:1986;367-376.
31. 3H]captopril Localization to a striato-nigral pathway. Proc. Natl. Acad. Sci. USA. 81:1984;1599-1603.
32. Supattapone S., Fricker L. D., Snyder S. H. Purification and characterization of a membrane bound enkephalin convertase. J. Neurochem. 42:1984;1017-1023.
33. Tani M. Angiotensin converting enzyme in human brain Discrete localization and biochemical properties. Jpn. Heart J. 32:1991;189-201.
34. Terenius L. Opiate receptors - The historical breakthrough in drug research. Biochem. Soc. Symp. 59:1993;13-25.
35. Turner A. J., Barnes K. Neuropeptidases Candidate enzymes and techniques for study. Biochem. Soc. Trans. 22:1994;122.
36. Vlaskovska M., Nylander I., Kasakov L., Silberring J., Terenius L. Opiate sensitive dynorphin conversion in SH-SY5Y human neuroblastoma cells Evidence for inhibition by dynorphin related peptides. Analgesia. 1:(4\N6):1995;821-824.
37. Wagner J. J., Terman G. W., Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature. 363:1993;451-454.
38. Walker J. M., Moises H. C., Coy D. H., Baldrighi G., Akil H. Non-opiate effects of dynorphin and des-Tyr-dynorphin. Science. 218:1982;1136-1138.
39. Weisskopf M. G., Zalutsky R. A., Nicoll R. A. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fiber synapses and modulates long term potentiation. Nature. 362:1993;423-427.
40. +-depolarization, lesions and peptidase inhibition. Neuroscience. 63:1994;415-425.